SCHEMBL30801732

SCHEMBL30801732

N#Cc1cccc(-c2cnc(N3CCN4CCNC[C@@H]4C3=O)s2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 7/20 0.42
CHEK1 O14757 4/20 0.38
CYP1A2 P05177 3/20 0.37
CYP3A4 P08684 3/20 0.37
ALDH1A1 P00352 2/20 0.37
CYP2C9 P11712 2/20 0.37
HPGD P15428 2/20 0.37
CASP1 P29466 2/20 0.37
CASP7 P55210 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HSD17B10 Q99714 2/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
HRH3 Q9Y5N1 1/20 0.36
MLYCD O95822 1/20 0.36
BACE1 P56817 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
DRD2 P14416 1/20 0.35
DRD3 P35462 1/20 0.35
PRF1 P14222 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30801856 1.00 USP30 (0.42) USP30CHEK1CYP1A2CYP3A4ALDH1A1
SCHEMBL30801881 0.88 USP30 (0.45) USP30CHEK1ALDH1A1HPGD
SCHEMBL30801791 0.88 USP30 (0.45) USP30CHEK1ALDH1A1HPGD
SCHEMBL30801827 0.87 USP30 (0.37) USP30CHEK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL30801787 0.87 USP30 (0.37) USP30CHEK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL23113636 0.85 USP30 (0.51) USP30
SCHEMBL23113601 0.85 USP30 (0.51) USP30
SCHEMBL30801892 0.85 USP30 (0.51) USP30
SCHEMBL23573945 0.85 USP30 (0.51) USP30
SCHEMBL30801929 0.85 USP30 (0.51) USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3793997-B1 FUSED BICYCLIC COMPOUNDS USEFUL AS UBIQUITIN-SPECIFIC PEPTIDASE 30 INHIBITORS FORMA THERAPEUTICS INC (US) 2024-03-13 EP claimed